Literature DB >> 8549379

Sparfloxacin empirical therapy in community-acquired pneumonia. Results of a meta-analysis of 2 comparative studies.

G G Grassi1, I Brumpt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8549379     DOI： 10.2165/00003495-199500492-00115

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  1 in total

1.  The concentration of sparfloxacin in lung tissues after single and multiple oral doses.

Authors:  D Honeybourne; I Greaves; D R Baldwin; J M Andrews; M Harris; R Wise
Journal:  Int J Antimicrob Agents       Date:  1994-08       Impact factor: 5.283
  1 in total
  2 in total

Review 1.  Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections.

Authors:  K L Goa; H M Bryson; A Markham
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

Review 2.  Practical considerations and guidelines for the management of community-acquired pneumonia.

Authors:  R G Finch; M A Woodhead
Journal:  Drugs       Date:  1998-01       Impact factor: 11.431
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.